Study objective: To assess the impact of substituting noninvasive diagnostic studies for Swan-Ganz catheter (SGC) placement in the evaluation of acutely ill patients. Design: Modified decision analysis. Methods: Using published studies that define effectiveness of clinical examination, echocardiography, and SGC placement to diagnose pulmonary edema, an analysis of the impact of substituting three diagnostic approaches using (1) clinical assessment (CA), (2) M-mode twodimensional transthoracic echocardiography (EC), or (3) CA then EC if necessary for SGC placement was considered. Study population: Patients with acute respiratory distress and radiographic findings of pulmonary edema, and ICU patients with hypotension and/or pulmonary edema without acute cardiac ischemia. Interventions: Three approaches using noninvasive studies were substituted for placement of SGC in the initial evaluation of pulmonary edema.
P
atients presenting with acute onset of respiratory failure and pulmonary edema are a common and difficult clinical dilemma. Although caused by a variety
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of disease processes, pulmonary edema is produced by two pathophysiologic mechanisms: cardiogenic, due to increased pulmonary capillary hydrostatic pressures; or noncardiogenic, due to increased per-meability of the alveolar capillary membrane. 1, 2 Current diagnostic approaches to pulmonary edema require that the clinician distinguish cardiogenic from noncardiogenic pulmonary edema, which is often accomplished by measuring pulmonary capillary wedge pressure (PCWP) with a Swan-Ganz catheter (SGC). 1 Thus, placement of a SGC has become the standard of care in the evaluation of pulmonary edema.
The overall impact of SGC use on patient outcome in the evaluation of pulmonary edema has not been clearly defined. It would seem obvious that defining the underlying mechanism leading to pulmonary edema should result in improved patient care. However, several observational studies of critically ill patients, including patients with pulmonary edema, showed increased mortality rather than improved survival associated with SGC use. [3] [4] [5] [6] [7] These studies have been criticized due to the lack of an appropriate control group in which placement of a SGC was withheld. 8 A properly designed study of SGC placement in critically ill patients with a primary end point of survival was attempted; however, the study was terminated due to failure to accrue sufficient numbers of patients. 9 Unwillingness of attending physicians to participate in a study in which placement of SGC was randomized was cited by the study authors as the major cause of low patient accrual.
The mechanism of pulmonary edema can also be assessed by noninvasive studies including simple clinical assessment (CA) and two-dimensional transthoracic echocardiography (EC). 10 -16 Use of noninvasive studies could provide important information as to the pathogenesis of pulmonary edema without any direct procedure-related morbidity or mortality. However, substituting noninvasive studies to evaluate pulmonary edema has not been widely accepted due to the lack of evidence establishing the accuracy of this approach. Moreover, SGC placement is perceived to provide definitive quantitative information, whereas noninvasive tests provide subjective and qualitative information. 17 Use of decision analysis, clinical case modeling, and other hypothetical methods of clinical analysis can provide useful clinical information when human studies are deemed unethical or infeasible. This study estimates whether alternative strategies to using SGC, particularly those relying on CA and/or EC, could be reasonably used to diagnose volume overload. This would allow treatment without invasive monitoring or the adverse events associated with SGC placement. The variables used in this analysis to compare strategies were the number of tests needed to diagnose (NTND) all cases of volume overload and the morbidity and mortality related to each diagnostic strategy.
Materials and Methods

Analysis
The baseline model considered the clinical scenario of adult patients presenting with acute respiratory failure, radiographic findings of pulmonary edema, and no evidence of acute myocardial ischemia. Four different diagnostic approaches were evaluated (Fig 1) . The standard approach used SGC placement in all patients. An alternative approach relied on CA (based on a directed physical examination, chest radiograph, and ECG interpretation) to detect volume overload. If CA reflected volume overload, a trial of diuretics would be given. A response to diuretics would not require further assessment. Either no response to diuretics or a failure to detect volume overload on CA would lead to SGC placement. Another approach was to use EC in all patients with outcomes patterned after the CA approach. A third alternative approach was to use CA as the first step. If CA detected volume overload, then the approach described for CA alone would be used. If CA did not detect volume overload, the more sensitive diagnostic test, EC, would be performed. This reflects the currently accepted, conservative clinical management of this problem. 2 A decision analysis modified to focus on accuracy of diagnosis and on the specific performance characteristics of sensitivity and false-positive rate was used to calculate the overall number of procedures required to correctly diagnose the cause of pulmonary edema. A population with known prevalence of volume overload as the cause of pulmonary edema was assumed, and noninvasive studies with known performance characteristics of sensitivity and false-positive rate were used to derive the number of procedures required to make a correct diagnosis of volume overload. A study population size of 10,000 patients was assumed to yield outcome results that were easily interpreted. The total number of SGCs placed and total procedures performed for each approach were calculated from the performance characteristics (sensitivity and false-positive rate) of CA or EC to diagnose volume overload. CA and EC performance characteristics were derived from pooled data of relevant studies that were identified by search of the medical literature. Similarly, total numbers of SGC-related serious complications and deaths were calculated based on morbidity and mortality estimates derived from pooled data of relevant studies. The NTND all cases of volume overload was derived as a measure of workload and efficiency of evaluation that is easily interpreted by the clinician. 18 The NTND was defined as the total number of diagnostic tests required to identify all cases of volume overload for each diagnostic approach.
Baseline Estimates
Performance characteristics of CA and EC for diagnosing volume overload were determined by review of the medical literature. The authors searched the MEDLINE database from 1966 to 1998 using the following combinations of key words: volume overload (or congestive heart failure) and sensitivity/ specificity of diagnosis, ARDS/diagnosis and PCWP, ARDS/ diagnosis and volume overload (or congestive heart failure)/ diagnosis, respiratory insufficiency and PCWP, pulmonary edema and ARDS, precision and accuracy of diagnosis of pulmonary edema and CA, and precision and accuracy of diagnosis of pulmonary edema and echocardiography. Several criteria were used to identify relevant articles for analysis: (1) the study population had to consist of patients presenting with acute respiratory failure and diffuse infiltrates on chest radiography, (2) study patients had to have both CA and SGC placement or EC and SGC placement to distinguish volume overload from ARDS, (3) hemodynamic and quantitative echocardiographic data had to be presented in either tabular or graphic form, and (4) direct correlation of all hemodynamic data to the diagnosis of volume overload by CA or EC had to be a focus of the article. All relevant articles were reviewed by the authors for quality. Only articles meeting high-quality standards including prospective study design and at least Ն 20 patients studied consecutively were included for analysis. Articles were excluded if the data were obtained retrospectively, if the primary focus of the study was not on the accuracy of diagnosis of volume overload, if the article was a review article or meta-analysis, or if the article studied patients in a nonconsecutive fashion.
The hemodynamic standard for diagnosis of volume overload was a PCWP Ն 18 mm Hg. This value was cited by the American-European consensus conference on the definition of the ARDS as the PCWP that distinguished ARDS from volume overload. 2 Moreover, a PCWP Ն 18 mm Hg was found by Forrester et al 1 to correlate closely with clinical evidence of pulmonary edema in patients with acute myocardial ischemia and volume overload. Criteria to diagnose volume overload by CA included the presence of elevated neck veins, displaced apical pulse, lower-extremity edema, bibasilar rales, enlarged cardiac silhouette, and/or prior myocardial infarction on an ECG. 10, 19 Criteria for the diagnosis of volume overload by EC included the presence of cardiac chamber enlargement and reduced stroke volume. 12, 14 The results of the searches were combined to yield 345 citations. Overall, 14 relevant articles were identified as meeting the study criteria and were reviewed by one of the authors. Specific data from these articles were pooled to derive the most reliable and accurate assumptions. Results showed a sensitivity of 73% and false-positive rate of 50% for diagnosing volume overload by CA (n ϭ 98 pooled patients), 16, 20 and a sensitivity of 89% and false-positive rate of 67% to diagnose volume overload by EC (n ϭ 20 patients; Table 1 ). 14 To calculate the number of correct and incorrect diagnoses of volume overload that each approach produced, it was necessary to determine the prevalence of volume overload in the study population. The authors determined this by review of studies that diagnosed volume overload in patients presenting with acute respiratory failure and pulmonary edema. Pooled data from four studies with a total number of 224 patients showed that the prevalence of volume overload in this population was 30%. 16,20 -22 Similarly, morbidity and mortality rates due to SGC placement were derived from four studies involving Ͼ 5,000 patients. Pooled data from these studies showed SGC procedure-related serious complications and deaths were 4% and 0.1%, respectively. [23] [24] [25] [26] 
Sensitivity Analysis
All outcome calculations were repeated after making changes in study population characteristics and baseline estimates. The new study population consisted of critically ill patients in an ICU who were being evaluated for hypotension, pulmonary edema, or both. Study population exclusion criteria included age Ͻ 16 years and volume overload due to acute myocardial ischemia or infarction. Operating characteristics for CA and EC in diagnosing volume overload in this population were derived as previously described. Sensitivity and false-positive rates for diagnosing volume overload by CA were 40% and 21% (n ϭ 290 pooled patients), and for EC were 77% and 62%, respectively (n ϭ 40 patients; Table 1 ). 14, [27] [28] [29] Pooled data from four studies (n ϭ 330 pooled patients) gave a prevalence of volume overload in this population of 40%. 14,27-29 Assumed SGC-related morbidity and mortality were 4% and 0.1%, respectively.
Further analyses were conducted in which the performance characteristics of noninvasive tests were assumed rather than calculated from pooled data. Baseline assumptions for CA were changed to a sensitivity of 90% and a false-positive rate of 10%. For EC, baseline assumptions were changed to 95% sensitivity Figure 1 . This diagram describes the four diagnostic approaches analyzed in the study. The standard approach involves the placement of a SGC to diagnose the cause of pulmonary edema. The CA approach uses a directed physical examination, chest radiograph, and ECG to detect volume overload as the cause of pulmonary edema. If CA diagnoses volume overload, a diuretic trial is given. Patients not responding to diuretics are further evaluated by SGC placement. If CA shows no volume overload, a SGC is placed to confirm the diagnosis. The EC approach would follow the same steps, except that the initial assessment would be with M-mode EC. The CA followed by EC approach involves an initial evaluation by CA. If this evaluation shows volume overload, then a diuretic trial is given and response is determined. If CA diagnoses no volume overload, then EC is performed according to the prior EC approach. Cxr ϭ chest radiograph.
and 20% false prevalence rates. Changes in procedure-related adverse events were not altered because these changes would affect the outcome results of all diagnostic approaches equally.
Results
Diagnostic Approaches and Estimates
According to the first diagnostic approach, all initial evaluations of patients would be by insertion of a SGC, and all diagnoses of volume overload by SGC placement (ie, PCWP Ն 18 mm Hg) would be assumed to be true-positive. Thus, 3,000 patients (10,000 patients multiplied by the prevalence of volume overload in the population, 0.3) would have a PCWP Ն 18 mm Hg and would receive a diagnosis of volume overload. The remaining 7,000 patients would have a PCWP Ͻ 18 mm Hg and would receive a diagnosis of no volume overload. There would be 10,000 SGCs placed to identify all cases of volume overload, which results in a NTND of 10,000 diagnostic tests (Table 2) . Assuming a procedure-related morbidity of 4% and mortality of 0.1%, the initial evaluation of 10,000 patients with pulmonary edema by SGC placement would lead to 400 adverse events and 10 deaths.
Initial evaluation by the CA approach results in 5,690 patients with a diagnosis of volume overload (Fig 2) . This value comes from the number of patients who received a correct diagnosis of volume
who received an incorrect diagnosis of volume overload (7,000 patients without volume overload multiplied by the false-positive rate of CA to diagnose volume overload, 0.5). The 2,190 patients who received a correct diagnosis of volume overload would respond to diuretic therapy; however, the 3,500 patients who received an incorrect diagnosis of volume overload would not respond and would require SGC placement to further evaluate the cause of pulmonary edema. The remaining 4,310 patients would receive a diagnosis of no volume overload (simply calculated as 10,000 subtracted from 5,690 patients with a diagnosis of volume overload), and would have a SGC placed to evaluate the cause of pulmonary edema. Overall, there would be 7,810 SGCs placed, a NTND all cases of volume overload of 7,810 diagnostic tests (Table 2 ). Evaluation by CA would lead to 312 adverse events and 7.8 deaths from SGC.
Using similar steps as for CA, the EC approach leads to 7,360 SGCs placed, and a NTND all cases of volume overload of 17,360 diagnostic tests (Fig 3 and Table 2 ). Evaluation by EC would lead to 293 adverse events and 7.3 deaths from SGC. For the CA then EC approach, patients are initially evaluated by CA. If volume overload is diagnosed using CA, the patient is given a trial of diuretics. However, if no volume overload is diagnosed using CA, the patient is evaluated further by EC. This approach leads to 7,080 SGCs placed, and a NTND all cases of volume overload of 11,390 diagnostic tests (Fig 4 and Table  2) . Evaluation by CA then EC results in 283 adverse events and 7.1 deaths from SGC.
As summarized in Table 2 , all approaches involving CA or EC lead to a reduction in procedurerelated serious complications and deaths, but affect the NTND variably when compared to the SGC approach. The fewest procedures are found in the CA approach, which also leads to 88 fewer serious complications and 2.2 fewer deaths, compared to the SGC approach. Similar results were obtained by the EC approach, but an additional 9,520 procedures were required to avoid 19 serious complications and 0.5 deaths, compared to the CA approach. The CA then EC approach required 3,580 additional procedures to avoid 29 serious complications and 0.7 deaths, compared to the CA approach.
Sensitivity Analysis
Outcome calculations were repeated for a new study population consisting of critically ill patients in an ICU with hypotension, pulmonary edema, or both. The prevalence of volume overload in this population was derived to be 40%, and estimates of CA and EC performance characteristics were recalculated (Table 1) . Again, the CA approach was the only approach that led to reductions in all adverse outcomes and in the NTND (Table 3) . Compared to the first study population, a greater benefit in adverse outcomes occurred in the EC, and CA then EC approaches, compared to the CA-only approach. However, these benefits required the performance of an additional 8,520 diagnostic tests for the EC approach and 6,920 diagnostic tests for the CA then EC approach. Outcome calculations were also repeated after assuming performance characteristics that strongly favored the noninvasive approaches over SGC placement (Table 4) . Under these conditions, the CA approach results in 2,700 fewer diagnostic studies, a decrease in the NTND, and elimination Figure 2 . This diagram shows the results produced by the second diagnostic approach. A sensitivity of 73% and false-positive rate of 50% for CA to diagnose volume overload was derived from the literature. According to this approach, 5,690 would receive a diagnosis of volume overload; of these, 2,190 patients would receive a correct diagnosis, would respond to diuretics, and would not require SGC placement. Among the remaining 3,500 patients who received an incorrect diagnosis, all would not respond to diuretics and would require SGC placement for further evaluation. Also, 4,310 patients would receive a diagnosis of no volume overload and would have a SGC placed for further evaluation. Figure 3 . This diagram shows the results produced by the third diagnostic approach. A sensitivity of 89% and false-positive rate of 67% for EC to diagnose volume overload was derived from the literature. According to this approach, 7,360 patients would receive a diagnosis of volume overload; of these, 2,640 patients would receive a correct diagnosis, would respond to diuretics, and would not require SGC placement. Among the remaining 4,720 patients who received an incorrect diagnosis, all would not respond to diuretics and would require SGC placement for further evaluation. Also, 2,640 patients would receive a diagnosis of no volume overload and would have a SGC placed for further evaluation. of 108 serious complications and 2.7 deaths, compared to the SGC approach. Comparison of the three noninvasive approaches shows that the CA approach produced the fewest number of procedures and the lowest NTND. Compared to the CA approach, EC, and CA then EC approaches lead to 9,850 and 6,315 more diagnostic tests, respectively, and increases in the NTND, while producing only modestly fewer serious complications and deaths.
Discussion
Many outcome-based studies have shown that SGC use in critically ill patients leads to unexpected diagnoses, changes in patient management, and purported improved survival, although many of these studies lack statistical power to make valid conclusions. 20, 27, 28, 30, 31 In contrast, several large observational studies have demonstrated increased mortality in patients managed with SGC, compared to patients managed without SGC. 3, 10, 12, 15 Conflicting results raise doubts about the benefits of SGC use and have led to an increased interest in other methods to obtain hemodynamic information. Echocardiography is an easy noninvasive test to obtain hemodynamic information and is clearly a safer alternative to Figure 4 . This diagram shows the results produced by the fourth diagnostic approach. This approach first evaluates patients by CA, and those patients who received a diagnosis of no volume overload are further evaluated by EC. As described in Figure 2 , 5,690 patients would have volume overload diagnosed and 2,190 patients would respond to diuretics, while 3,500 patients would have a SGC placed after no response to diuretics. EC would evaluate the remaining 4,310 patients who received a diagnosis of no volume overload by CA. Among these patients, 3,070 patients would receive a diagnosis of volume overload; of these, 730 patients would receive a correct diagnosis, would respond to diuretics, and would require SGC placement. Among the remaining 2,340 patients who received an incorrect diagnosis, all would not respond to diuretics and would require SGC placement for further evaluation. EC would also diagnose no volume overload in 1,240 patients, and a SGC would be placed in all of these patients. SGC placement from the standpoint of procedurerelated adverse events. 10 -12,15 However, substituting echocardiography or any other noninvasive studies for SGC placement would be premature, since evidence is lacking that this could be done reliably and to the patient's overall benefit. Moreover, completing such studies may be difficult and may be met with ethical concerns. The purpose of this study was to better understand the impact of substituting noninvasive studies for SGC placement in the diagnosis of acutely ill patients without incurring ethical considerations. To accomplish this objective, we used a modified decision analysis design and data from relevant human studies on performance characteristics of SGC and noninvasive diagnostic studies to estimate the impact of substituting CA, EC, or both for SGC placement in the initial assessment of patients with acute pulmonary edema. The purpose in selecting the key performance characteristics studied was to maximize sensitivity, to detect the most patients possible with volume overload, to minimize the false-positive rate, and to reduce the number of patients misleadingly labeled as having volume overload. Our results suggest that a substantial number of patients would require SGC placement despite evaluation with noninvasive studies. However, by noninvasive methods, some patients receive a correct diagnosis of pulmonary edema due to volume overload and avoid SGC placement. Thus, substituting noninvasive studies for SGC placement leads to an overall reduction in the number of SGCs placed and a 10 to 30% reduction in procedurerelated complications and deaths. However, in absolute numbers, the reductions in complications and deaths due to use of some noninvasive studies are small, while there are substantial increases in the NTND all cases of volume overload. The EC approach resulted in an additional 500 to 3,000 echocardiographic procedures to avoid one death, compared to the SGC approach. In contrast, the CA approach led to 1,200 to 2,700 fewer procedures while avoiding 1.6 to 2.7 deaths. The CA approach was the only noninvasive approach that reduced total procedure-related complications and deaths while at the same time reducing the NTND all cases of volume overload.
The authors believe that the assumptions contained in the different diagnostic approaches reflected the available treatment options and meet accepted standards of practice. Currently, there is no specific treatment of ARDS other than supportive therapy. A diuretic trial in an ARDS patient would be low risk for causing harm to the patient. Indeed, diuretics may be of some benefit in ARDS patients. [32] [33] [34] Placement of a SGC in all patients with undiagnosed pulmonary edema to confirm the diagnosis of ARDS is a conservative but well-accepted practice. 2 Some clinicians may choose not to place a SGC in selected cases of pulmonary edema in which the diagnosis of ARDS seems obvious, which would be contrary to the assumptions underlying this study. However, all relevant articles used to derive operating characteristics in this study involved patients in whom placement of a SGC was deemed necessary by the attending physician for initial evaluation of pulmonary edema.
We obtained similar results when we applied our methods to a different population: critically ill patients in an ICU with hypotension, pulmonary edema, or both. In this population, however, the benefits of the CA approach are less, more SGCs are placed, and more procedure-related serious complications and deaths occur. Approaches using EC had fewer serious complications and deaths, compared to the SGC approach, but EC approaches continued to have a high NTND all cases of volume overload. In further sensitivity analysis in which the operating characteristics of CA and EC were improved, results showed again that the CA approach led to substantial benefit in procedure-related complications and deaths that were similar to the EC, or CA then EC approaches. However, the CA approach was the only approach that produced reductions in the NTND all cases of volume overload.
Although in need of careful interpretation, our analysis leads to several considerations. Substituting noninvasive tests for placement of a SGC may have only a modest impact on overall patient care. Absolute reductions in procedure-related adverse events were very small, which is largely due to the small number of complications and deaths associated with insertion of a SGC. Our data also suggest that replacing the SGC with echocardiography in the initial evaluation of patients with pulmonary edema would reduce absolute procedure-related adverse events slightly, but substantially add to total number of procedures performed. In contrast, the results of the CA approach showed that procedure-related adverse events were reduced while also leading to reductions in the NTND volume overload and the total number of procedures performed. These findings raise the point that resource utilization may become an important determinant in assessing the overall value of replacing the SGC with noninvasive tests.
This study used the results of numerous reliable and well-designed studies to form assumptions and projections. However, our conclusions are limited in that the study focus was only on procedure-related events and on the initial evaluation of pulmonary edema and/or hypotension in the absence of acute myocardial ischemia. Also, study methods do not take into account the clinical events following the decision to place a SGC or to perform a noninvasive test. As such, recommendations on the proper use of SGC cannot be formulated; however, our results do provide useful insights in an area in which studies have been limited by study design and ethical problems. Our results show that substituting noninvasive studies, particularly CA, may have a survival and resource utilization benefit and should reassure clinicians that controlled studies in which SGC placement may be withheld from some study patients are reasonable. Moreover, our sensitivity analysis demonstrates that improving the performance characteristics of CA for diagnosing volume overload may provide even greater benefit.
In summary, using a modified decision analysis of a specific clinical problem involving SGC placement, we found that substitution of noninvasive studies for SGC insertion reduces overall procedure-related adverse events. Substitution of echocardiography for SGC placement also results in an increase in the NTND all cases of volume overload and the total number of procedures performed. Use of CA only leads to reductions in both the NTND and in the total number of procedures performed. Future prospective, sufficiently powered studies aimed at replacing SGC placement with noninvasive tests could reasonably include a control group consisting of CA only, and should include measures of resource utilization.
